Bystander activation of iNKT cells occurs during conventional T-cell alloresponses

American Journal of Transplantation

Volumn 12, Issue 3, 2012, Pages 590-599

  Jukes, J P ^a,b   Wood, K J ^a   Jones, N D ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Allorecognition; bystander activation; iNKT cells; transplantation

Indexed keywords

ALLOANTIGEN; CD1D ANTIGEN; CYTOKINE; GAMMA INTERFERON; GLYCOLIPID; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; RNA; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; BYSTANDER EFFECT; COCULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SKIN GRAFT; SKIN TRANSPLANTATION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1D; APOPTOSIS; BLOTTING, WESTERN; BYSTANDER EFFECT; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; INTERLEUKIN-2; ISOANTIGENS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; NATURAL KILLER T-CELLS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION TOLERANCE;

EID: 84857648677     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03847.x     Document Type: Article

References (48)

1. Balk SP, Bleicher PA, Terhorst C,. Isolation and characterization of a cDNA and gene coding for a fourth CD1 molecule. Proc Natl Acad Sci USA 1989; 86: 252-256. (Pubitemid 19036365)
2. Game DS, Lechler RI,. Pathways of allorecognition: Implications for transplantation tolerance. Transpl Immunol 2002; 10: 101-108.
3. Morita M, Motoki K, Akimoto K, et al,. Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice. J Med Chem 1995; 38: 2176-2187.
4. Amprey JL, Im JS, Turco SJ, et al,. A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J Exp Med 2004; 200: 895-904. (Pubitemid 39362925)
5. Fischer K, Scotet E, Niemeyer M, et al,. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc Natl Acad Sci USA 2004; 101: 10685-10690. (Pubitemid 38955803)
6. Kinjo Y, Wu D, Kim G, et al,. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005; 434: 520-525. (Pubitemid 40477061)
7. Mattner J, Debord KL, Ismail N, et al,. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005; 434: 525-529. (Pubitemid 40477062)
8. Kinjo Y, Tupin E, Wu D, et al,. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 2006; 7: 978-986. (Pubitemid 44263912)
9. Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB,. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 2003; 4: 1230-1237. (Pubitemid 37540692)
10. Paget C, Mallevaey T, Speak AO, et al,. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 2007; 27: 597-609. (Pubitemid 47628833)
11. Salio M, Speak AO, Shepherd D, et al,. Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation. Proc Natl Acad Sci USA 2007; 104: 20490-20495.
12. Matsuda JL, Mallevaey T, Scott-Browne J, Gapin L,. CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system. Curr Opin Immunol 2008; 20: 358-368.
13. Carnaud C, Lee D, Donnars O, et al,. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 1999; 163: 4647-4650. (Pubitemid 29501223)
14. Eberl G, MacDonald HR,. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur J Immunol 2000; 30: 985-992. (Pubitemid 30216213)
15. Vincent MS, Leslie DS, Gumperz JE, Xiong X, Grant EP, Brenner MB,. CD1-dependent dendritic cell instruction. Nat Immunol 2002; 3: 1163-1168.
16. Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM,. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med 2003; 198: 267-279. (Pubitemid 36987852)
17. Hermans IF, Silk JD, Gileadi U, et al,. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J Immunol 2003; 171: 5140-5147. (Pubitemid 37432797)
18. Galli G, Nuti S, Tavarini S, et al,. Innate immune responses support adaptive immunity: NKT cells induce B cell activation. Vaccine 2003; 21 Suppl 2: S48-S54. (Pubitemid 36603316)
19. Silk JD, Hermans IF, Gileadi U, et al,. Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. J Clin Invest 2004; 114: 1800-1811. (Pubitemid 40385536)
20. De Santo C, Salio M, Masri SH, et al,. Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J Clin Invest 2008; 118: 4036-4048.
21. De Santo C, Arscott R, Booth S, et al,. Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A. Nat Immunol 2010; 11: 1039-1046.
22. Van Kaer L,. Natural killer T cells as targets for immunotherapy of autoimmune diseases. Immunol Cell Biol 2004; 82: 315-322. (Pubitemid 38870026)
23. Brigl M, Brenner MB,. How invariant natural killer T cells respond to infection by recognizing microbial or endogenous lipid antigens. Semin Immunol 2009.
24. Seino KI, Fukao K, Muramoto K, et al,. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci USA 2001; 98: 2577-2581. (Pubitemid 32209524)
25. Ikehara Y, Yasunami Y, Kodama S, et al,. CD4(+) Valpha14 natural killer T cells are essential for acceptance of rat islet xenografts in mice. J Clin Invest 2000; 105: 1761-1767. (Pubitemid 30421757)
26. Yang SH, Jin JZ, Lee SH, et al,. Role of NKT cells in allogeneic islet graft survival. Clin Immunol 2007; 124: 258-266. (Pubitemid 47247615)
27. Toyofuku A, Yasunami Y, Nabeyama K, et al,. Natural killer T-cells participate in rejection of islet allografts in the liver of mice. Diabetes 2006; 55: 34-39. (Pubitemid 43348456)
28. Yasunami Y, Kojo S, Kitamura H, et al,. Valpha14 NK T cell-triggered IFN-gamma production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets. J Exp Med 2005; 202: 913-918. (Pubitemid 41398198)
29. Oh K, Kim S, Park SH, et al,. Direct regulatory role of NKT cells in allogeneic graft survival is dependent on the quantitative strength of antigenicity. J Immunol 2005; 174: 2030-2036. (Pubitemid 40223945)
30. Jukes JP, Wood KJ, Jones ND,. Natural killer T cells: A bridge to tolerance or a pathway to rejection? Transplantation 2007; 84: 679-681. (Pubitemid 47480650)
31. Li L, Huang L, Sung SS, et al,. NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury. J Immunol 2007; 178: 5899-5911. (Pubitemid 46674387)
32. Jones ND, Carvalho-Gaspar M, Luo S, Brook MO, Martin L, Wood KJ,. Effector and memory CD8+ T cells can be generated in response to alloantigen independently of CD4+ T cell help. J Immunol 2006; 176: 2316-2323. (Pubitemid 43201679)
33. Carvalho-Gaspar M, Billing JS, Spriewald BM, Wood KJ,. Chemokine gene expression during allograft rejection: Comparison of two quantitative PCR techniques. J Immunol Methods 2005; 301: 41-52. (Pubitemid 40961974)
34. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408. (Pubitemid 34164012)
35. Grubin CE, Kovats S, deRoos P, Rudensky AY,. Deficient positive selection of CD4 T cells in mice displaying altered repertoires of MHC class II-bound self-peptides. Immunity 1997; 7: 197-208. (Pubitemid 27392012)
36. Malek TR, Castro I,. Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity 2010; 33: 153-165.
37. Patterson S, Chaidos A, Neville DC, et al,. Human invariant NKT cells display alloreactivity instructed by invariant TCR-CD1d interaction and killer Ig receptors. J Immunol 2008; 181: 3268-3276.
38. Tomala J, Chmelova H, Strohalm J, et al,. Antitumor activity of IL-2/anti-IL-2 mAb immunocomplexes synergizes with that of HPMA copolymer-bound doxorubicin conjugate due to its low immunosuppressive activity. Int J Cancer 2010.
39. Moll M, Snyder-Cappione J, Spotts G, Hecht FM, Sandberg JK, Nixon DF,. Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2. Blood 2006; 107: 3081-3083.
40. Jiang X, Shimaoka T, Kojo S, et al,. Cutting edge: Critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance. J Immunol 2005; 175: 2051-2055. (Pubitemid 41113808)
41. Jiang X, Kojo S, Harada M, Ohkohchi N, Taniguchi M, Seino KI,. Mechanism of NKT cell-mediated transplant tolerance. Am J Transplant 2007; 7: 1482-1490. (Pubitemid 46776265)
42. Zeng D, Lewis D, Dejbakhsh-Jones S, et al,. Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J Exp Med 1999; 189: 1073-1081. (Pubitemid 29169824)
43. Sonoda KH, Taniguchi M, Stein-Streilein J,. Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells. J Immunol 2002; 168: 2028-2034. (Pubitemid 34135807)
44. Leveson-Gower DB, Olson JA, Sega EI, et al,. Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism. Blood 2011; 117: 3220-3229.
45. Konieczny BT, Dai Z, Elwood ET, et al,. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 1998; 160: 2059-2064. (Pubitemid 28119882)
46. Wood KJ, Sawitzki B,. Interferon gamma: A crucial role in the function of induced regulatory T cells in vivo. Trends Immunol 2006; 27: 183-187.
47. Reilly EC, Wands JR, Brossay L,. Cytokine dependent and independent iNKT cell activation. Cytokine 2010; 51: 227-231.
48. Brigl M, Tatituri RV, Watts GF, et al,. Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J Exp Med 2011; 208: 1163-1177.